VRS
CLDX icon

Virginia Retirement Systems’s Celldex Therapeutics CLDX Stock Holding History

Virginia Retirement Systems’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,000
Closed -$288K – 1034
2021
Q1 		$288K Buy
+14,000
New +$321K ﹤0.01% 1004
2018
Q2 		– Sell
-1,733
Closed -$61K – 1046
2018
Q1 		$61K Hold
1,733
– – ﹤0.01% 971
2017
Q4 		$74K Sell
1,733
-254
-13% -$10.9K ﹤0.01% 970
2017
Q3 		$85K Sell
1,987
-213
-10% -$7.98K ﹤0.01% 1006
2017
Q2 		$82K Sell
2,200
-60
-3% -$2.65K ﹤0.01% 1036
2017
Q1 		$122K Sell
2,260
-293
-11% -$15.3K ﹤0.01% 1094
2016
Q4 		$136K Buy
2,553
+73
+3% +$4.15K ﹤0.01% 951
2016
Q3 		$150K Buy
+2,480
New +$154K ﹤0.01% 907

Other funds holding CLDX

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return